Medical Enhancement

To be published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section(ii) dated 15th May 2013 Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) New Delhi Dated 15th ___May 2013 25 Vaisakha Saka 1935 ORDER S.O. 1221(E).– In exercise of the powers conferred by section 3 of the Essential Commodities Act, 1955, (10 of 1955), and supersession of the Drug (Prices Control) Order, 1995, except as respect to things done or omitted to be done before such supersession, the Central Government hereby makes the following Order, namely:1. Short title and commencement.– (1) This Order may be called the Drugs (Prices Control) Order, 2013. (2) It shall come into force on the date of its publication in the Official Gazette. 2. Definitions.– (1) In this Order, unless the context otherwise requires,– (a) “Act” means the Essential Commodity Act, 1955 (10 of 1955); (b) "active pharmaceutical ingredients or bulk drug" means any pharmaceutical, chemical, biological or plant product including its salts, esters, isomers, analogues and derivatives, conforming to standards specified in the Drugs and Cosmetics Act, 1940 (23 of 1940) and which is used as such or as an ingredient in any formulation; (c) “brand” means a name, term, design, symbol, trademark or any other feature that identifies one seller’s drug as distinct from those of other sellers;

1

(d) "ceiling price" means a price fixed by the Government for Scheduled formulations in accordance with the provisions of this Order; (e) "dealer" means a person carrying on the business of purchase or sale of drugs, whether as a wholesaler or retailer and includes his agent; (f) "distributor" means a person engaged in the work of distribution of drugs and includes an agent or a stockist for stocking drugs for sale to a dealer; (g) “existing manufacturer” means manufacturer existing on the date of publication of this order in the Official Gazette. (h) "Form" means a form specified in the Second Schedule; (i)